-
Alan Skarbnik
Oncology / HematologyReal-World Treatment Patterns With Pacritinib For Myelofibrosis - 12 month(s) agoDear readers, To round up our myelofibrosis (MF) collection, I am highlighting some abstracts presented at the 2024 ASCO® Annual Meeting and an article discussing…
Lymphoma Updates With Alan Z. Skarbnik, MD
Oncology / HematologyDr. Skarbnik is director of the Lymphoma and CLL and Immune Effector Cell and Experimental Therapeutics Programs and associate director of the Transplantation and Cellular Therapy Program at the Novant Health Cancer Institute. He is also a clinical assistant professor at the University of North Carolina School of Medicine at Chapel Hill.
-
Alan Skarbnik
Oncology / HematologyDear readers, Today, I bring you a few more articles on myeloproliferative neoplasms (MPNs) and myelofibrosis (MF). First, I included an interesting observational study suggesting…
-
Alan Skarbnik
Oncology / HematologyDear readers, This collection provides a few more insights into the management of myelofibrosis (MF). One article discusses the choices of JAK-2 inhibitors, and another…
-
Alan Skarbnik
Oncology / HematologyDear readers, I hope you find this collection focusing on myelofibrosis (MF) useful. I included insights from several experts in the field, discussions surrounding the…
-
Alan Skarbnik
Oncology / HematologyASH 2023: Day 1 Papers on DLBCL - 1 year(s) agoDear readers, As we start #ASH2023, I’ll write about fascinating diffuse large B cell lymphoma (DLBCL) abstracts. Fortunately, there’s a lot to choose from. First,…
-
Alan Skarbnik
Oncology / Hematology'Chemo-Free' Regimen for R/R DLBCL - 1 year(s) agoDear readers, On our second sunny day of The 65th ASH Annual Meeting and Exposition, I want to share a few more interesting diffuse large…
-
Alan Skarbnik
Oncology / HematologyEfficacy of CAR-T Therapy for Patients Who Achieve CR - 1 year(s) agoDear readers, On this third day of the ASH Annual Meeting and Exposition, here are a few interesting abstracts in diffuse large B cell lymphoma…
-
Alan Skarbnik
Oncology / HematologyASH Wrap-Up: Final Takes on DLBCL Abstracts - 1 year(s) agoDear readers, This wraps another ASH Annual Meeting and Exposition! It was great being in San Diego, California, and enjoying the science. Here are my…
-
Alan Skarbnik
Oncology / HematologyWM, CLL, CAR-T - 2 year(s) agoThe ASH annual meeting has been great and as it comes close to an end, here are some interesting abstracts. A doublet combination for the…
-
Alan Skarbnik
Oncology / HematologyDLBCL abstracts - 2 year(s) agoToday I selected a few abstracts focusing on DLBCL. An important article focusing on quality of life analysis of the POLARIX study, showing no difference…